Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDIV × Breast Neoplasms × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 1682 INDUSTRY 521 NIH 136 NETWORK 56 OTHER_GOV 52 UNKNOWN 18 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Lipoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Osteosarcoma 1 Neutropenia 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lung Neoplasms 1 Liver Neoplasms 1 Esophageal Neoplasms 1 Cancer Cachexia 1 Breast Neoplasms 1 Barrett Esophagus 1 Anemia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00378638 2007-10-24

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

Chap, Linnea I., M.D.

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡